CDX | HYG | CDX / HYG | |
Gain YTD | 10.099 | 7.342 | 138% |
Net Assets | 391M | 19.9B | 2% |
Total Expense Ratio | 0.25 | 0.49 | 51% |
Turnover | 0.00 | 14.00 | - |
Yield | 11.16 | 5.70 | 196% |
Fund Existence | 4 years | 19 years | - |
CDX | HYG | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago30% |
Stochastic ODDS (%) | 1 day ago64% | 1 day ago39% |
Momentum ODDS (%) | 1 day ago84% | 1 day ago52% |
MACD ODDS (%) | 1 day ago88% | 1 day ago50% |
TrendWeek ODDS (%) | 1 day ago60% | 1 day ago55% |
TrendMonth ODDS (%) | 1 day ago79% | 1 day ago51% |
Advances ODDS (%) | 15 days ago80% | 9 days ago55% |
Declines ODDS (%) | 13 days ago60% | 5 days ago52% |
BollingerBands ODDS (%) | 1 day ago50% | N/A |
Aroon ODDS (%) | 1 day ago82% | 1 day ago46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
USCA | 41.56 | 0.27 | +0.66% |
Xtrackers MSCI USA Clmt Actn Eq ETF | |||
LODI | 25.28 | -0.02 | -0.10% |
AAM SLC Low Duration Income ETF | |||
SDS | 14.24 | -0.10 | -0.70% |
ProShares UltraShort S&P500 | |||
FTXH | 29.46 | -0.23 | -0.76% |
First Trust Nasdaq Pharmaceuticals ETF | |||
RSPR | 34.99 | -0.50 | -1.41% |
Invesco S&P 500® Equal Wt Real Estt ETF |